Both, BRCA1 and BRCA2 variants were associated with higher HRD scores in BRCA (FDR < 1.3 × 10−42) and OV (FDR < 5.0 × 10−12), BRCA2 (but not BRCA1) variants were also associated with higher HRD of PAAD (FDR = 1.3 × 10−17) and stomach cancer (STAD) (FDR = 6.7 × 10−17) (Table 1). The gene discussed is BRCA1; the disease is gastric neoplasm.